|
1
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta A and Dixon E: Epidemiology and risk
factors: Intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr.
6:101–104. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang H, Shen F, Han J, Shen YN, Xie GQ,
Wu MC and Yang T: Epidemiology and surgical management of
intrahepatic cholangiocarcinoma. Hepat Oncol. 3:83–91. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shaib YH, Davila JA, McGlynn K and
El-Serag HB: Rising incidence of intrahepatic cholangiocarcinoma in
the United States: A true increase? J Hepatol. 40:472–477. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tania M, Khan MA and Fu J: Epithelial to
mesenchymal transition inducing transcription factors and
metastatic cancer. Tumour Biol. 35:7335–7342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wen J, Luo KJ, Liu QW, Wang G, Zhang MF,
Xie XY, Yang H, Fu JH and Hu Y: The epithelial-mesenchymal
transition phenotype of metastatic lymph nodes impacts the
prognosis of esophageal squamous cell carcinoma patients.
Oncotarget. 7:37581–37588. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim MA, Lee HS, Lee HE, Kim JH, Yang HK
and Kim WH: Prognostic importance of epithelial-mesenchymal
transition- related protein expression in gastric carcinoma.
Histopathology. 54:442–451. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao H, Xu E, Liu H, Wan L and Lai M:
Epithelial-mesenchymal transition in colorectal cancer metastasis:
A system review. Pathol Res Pract. 211:557–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giannelli G, Koudelkova P, Dituri F and
Mikulits W: Role of epithelial to mesenchymal transition in
hepatocellular carcinoma. J Hepatol. 65:798–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vaquero J, Guedj N, Clapéron A, Nguyen
Ho-Bouldoires TH, Paradis V and Fouassier L: Epithelial-mesenchymal
transition in cholangiocarcinoma: From clinical evidence to
regulatory networks. J Hepatol. 66:424–441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang XY, Zhang C, Cai JB, Shi GM, Ke AW,
Dong ZR, Zhang PF, Fan J, Peng BG and Zhou J: Comprehensive
multiple molecular profile of epithelial mesenchymal transition in
intrahepatic cholangiocarcinoma patients. PLoS One. 9:e968602014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nitta T, Mitsuhashi T, Hatanaka Y,
Miyamoto M, Oba K, Tsuchikawa T, Suzuki Y, Hatanaka KC, Hirano S
and Matsuno Y: Prognostic significance of epithelial-mesenchymal
transition-related markers in extrahepatic cholangiocarcinoma:
Comprehensive immunohistochemical study using a tissue microarray.
Br J Cancer. 111:1363–1372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao X, Wang X, Wang Z, Dai L, Zhang G, Yan
Q and Zhou W: Clinicopathological and prognostic significance of
epithelial mesenchymal transition-related protein expression in
intrahepatic cholangiocarcinoma. Onco Targets Ther. 5:255–261.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ryu HS, Chung JH, Lee K, Shin E, Jing J,
Choe G, Kim H, Xu X, Lee HE, Kim DG, et al: Overexpression of
epithelial-mesenchymal transition-related markers according to cell
dedifferentiation: Clinical implications as an independent
predictor of poor prognosis in cholangiocarcinoma. Hum Pathol.
43:2360–2370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sobin LH, Gospodarowicz MK and Wittekind
CH: TNM Classification of Malignant Tumours. 7th edition.
Wiley-Blackwell; Oxford: pp. 122–128. 2009
|
|
21
|
Tian XG, Wang QZ, Li Y, Hu JH, Wu L, Ding
Q and Zhang C: The expression of S100A4 protein in human
intrahepatic cholangiocarcinoma: Clinicopathologic significance and
prognostic value. Pathol Oncol Res. 21:195–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shiozaki H, Tahara H, Oka H, Miyata M,
Kobayashi K, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M, et
al: Expression of immunoreactive E-cadherin adhesion molecules in
human cancers. Am J Pathol. 139:17–23. 1991.PubMed/NCBI
|
|
23
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hugo H, Ackland ML, Blick T, Lawrence MG,
Clements JA, Williams ED and Thompson EW: Epithelial-mesenchymal
and mesenchymal-epithelial transitions in carcinoma progression. J
Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mazzucchelli L: Protein S100A4: Too long
overlooked by pathologists? Am J Pathol. 160:7–13. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boye K and Maelandsmo GM: S100A4 and
metastasis: A small actor playing many roles. Am J Pathol.
176:528–535. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fabris L, Cadamuro M, Moserle L, Dziura J,
Cong X, Sambado L, Nardo G, Sonzogni A, Colledan M, Furlanetto A,
et al: Nuclear expression of S100A4 calcium-binding protein
increases cholangiocarcinoma invasiveness and metastasization.
Hepatology. 54:890–899. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mikami S, Katsube K, Oya M, Ishida M,
Kosaka T, Mizuno R, Mukai M and Okada Y: Expression of Snail and
Slug in renal cell carcinoma: E-cadherin repressor Snail is
associated with cancer invasion and prognosis. Lab Invest.
91:1443–1458. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kurrey NK, K A and Bapat SA: Snail and
Slug are major determinants of ovarian cancer invasiveness at the
transcription level. Gynecol Oncol. 97:155–165. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Emadi Baygi M, Soheili ZS, Schmitz I,
Sameie S and Schulz WA: Snail regulates cell survival and inhibits
cellular senescence in human metastatic prostate cancer cell lines.
Cell Biol Toxicol. 26:553–567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Blechschmidt K, Sassen S, Schmalfeldt B,
Schuster T, Höfler H and Becker KF: The E-cadherin repressor Snail
is associated with lower overall survival of ovarian cancer
patients. Br J Cancer. 98:489–495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kong D, Liang J, Li R, Liu S, Wang J,
Zhang K and Chen D: Prognostic significance of snail expression in
hilar cholangiocarcinoma. Braz J Med Biol Res. 45:617–624. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Poser I, Dominguez D, de Herreros AG,
Varnai A, Buettner R and Bosserhoff AK: Loss of E-cadherin
expression in melanoma cells involves up-regulation of the
transcriptional repressor Snail. J Biol Chem. 276:24661–24666.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cano A, Perez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang KJ, Wang DS, Zhang SY, Jiao XL, Li
CW, Wang XS, Yu QC and Cui HN: The E-cadherin repressor slug and
progression of human extrahepatic hilar cholangiocarcinoma. J Exp
Clin Cancer Res. 29:882010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang KJ, Zhang BY, Zhang KP, Tang LM, Liu
SS, Zhu DM and Zhang DL: Clinicopathologic significance of slug
expression in human intrahepatic cholangiocarcinoma. World J
Gastroenterol. 16:2554–2557. 2010. View Article : Google Scholar : PubMed/NCBI
|
